14-day Premium Trial Subscription Try For FreeTry Free
FRA:BZ9
Delisted

Booz Allen Hamilton Holding Corporation Stock Forecast

102.20€
+0 (+0%)
At Close: Dec 22, 2023
RSI low/high Values: [ 30 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Booz Allen Hamilton Holding Corporation Stock and on which exchange is it traded?
The symbol for Booz Allen Hamilton Holding Corporation is BZ9.F and it is traded on the FRA (Frankfurt Stock Exchange).

Should I buy or sell Booz Allen Hamilton Holding Corporation Stock?
Booz Allen Hamilton Holding Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Booz Allen Hamilton Holding Corporation Stock?
Booz Allen Hamilton Holding Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Booz Allen Hamilton Holding Corporation Stock.

What's the current price of Booz Allen Hamilton Holding Corporation Stock?
As of the end of day on the Dec 22, 2023, the price of an Booz Allen Hamilton Holding Corporation (BZ9.F) share was 102.20€.

What is the 52-week high and low for Booz Allen Hamilton Holding Corporation Stock?
The 52-week high for Booz Allen Hamilton Holding Corporation Stock is 114.60€ and the 52-week low is 81.96€.
Click to get the best stock tips daily for free!

About Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton Holding Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... BZ9.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT